RVTY vs CRL — Key Metrics
| Metric | RVTY (REVVITY INC) | CRL (CHARLES RIVER LABORATORIES INTERNATIONAL INC) |
|---|---|---|
| Price | 152.89 | 295.01 |
| Market Cap | 17.06 Billion | 14.08 Billion |
| P/E (TTM) | 73.15 | -61.59 |
| P/B (Quarterly) | 1.786 | 4.383 |
| P/S (TTM) | 5.86 | 3.52 |
| Net Profit Margin (TTM) | 8.2 | -6.0 |
| Gross Margin (TTM) | 55.0 | 32.7 |
| ROE (TTM) | 3.3 | -7.7 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
RVTY · REVVITY INC
Underperform
CRL · CHARLES RIVER LABORATORIES INTERNATIONAL INC
Greatly Underperform
Recommendation Summary
Stock RVTY is projected to underperform the market, stock CRL is projected to greatly underperform the market. Upfront Recommendation: RVTY.
Financial Metrics
Prices delayed ~15 min
| RVTY | Metrics | CRL |
|---|---|---|
| $152.89 | Price | $295.01 |
| — | Market Capitalization | — |
| 5.86 | Price to Sales | 3.52 |
| 29.92 | Price to FCF Ratio | 38.0 |
| 10.66 | Price to Gross Profit | 10.78 |
| 7.42 | Price to Current Assets | 9.21 |